Impaired Sensitivity to Thyroid Hormones is Associated with Central Obesity in Euthyroid Type 2 Diabetes Mellitus Patients with Overweight and Obesity
- PMID: 39280173
- PMCID: PMC11402367
- DOI: 10.2147/DMSO.S472550
Impaired Sensitivity to Thyroid Hormones is Associated with Central Obesity in Euthyroid Type 2 Diabetes Mellitus Patients with Overweight and Obesity
Abstract
Background: Thyroid hormone levels are associated with the distribution of body components in humans.
Objective: This study aimed to investigate the associations between thyroid hormone (TH) levels, central sensitivity to THs, and body composition in overweight and obese patients with euthyroid type 2 diabetes mellitus (T2DM).
Methods: This cross-sectional study included 1215 euthyroid T2DM patients (721 men and 494 women) aged 20-80 years. The thyroid hormone sensitivity indices included the thyroid feedback quartile-based index (TFQI), thyrotroph T3 resistance index (TT3RI), thyrotroph T4 resistance index (TT4RI), and thyroid-stimulating hormone index (TSHI). The appendicular fat ratio, trunk fat ratio, android fat ratio, gynoid fat ratio, and appendicular skeletal muscle mass (ASM) were measured via dual-energy X-ray absorptiometry.
Results: The data revealed a greater proportion of subjects with impaired central sensitivity to THs in the obese group. TFQIFT4 and TFQIFT3 levels were positively correlated with the upper limb fat ratio, lower limb fat ratio, gynoid fat ratio, and total fat ratio. TSHI was positively correlated with body mass index (BMI), upper limb fat ratio, lower limb fat ratio, trunk fat ratio, android fat ratio, gynoid fat ratio, total fat ratio, and appendicular skeletal muscle mass index (ASMI) in women. In men, TSHI was only positively correlated with upper limb fat ratio, lower limb fat ratio, and total fat ratio. Logistic regression analysis indicated that TT3RI and TFQIFT3 were independently and positively associated with central obesity and low muscle mass in overweight and obese men. No significant differences were found among the women.
Conclusion: THs central sensitivity is related to the body composition of euthyroid T2DM patients. Specifically, high levels of TT3RI and TFQIFT3 are associated with central obesity and low muscle mass in T2DM men with overweight and obesity.
Keywords: body components; euthyroid; fat ratio; muscle mass; obese; thyroid hormones central sensitivity.
© 2024 Chen et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
When Should the Treatment of Obesity in Thyroid Disease Begin?Biomedicines. 2025 Jan 10;13(1):157. doi: 10.3390/biomedicines13010157. Biomedicines. 2025. PMID: 39857741 Free PMC article. Review.
-
Correlation between thyroid function, sensitivity to thyroid hormones and metabolic dysfunction-associated fatty liver disease in euthyroid subjects with newly diagnosed type 2 diabetes.Endocrine. 2023 May;80(2):366-379. doi: 10.1007/s12020-022-03279-2. Epub 2022 Dec 20. Endocrine. 2023. PMID: 36539681
-
Impaired sensitivity to thyroid hormones is associated with increased body fat mass/muscle mass ratio (F/M) in the euthyroid population.Diabetol Metab Syndr. 2025 Apr 15;17(1):128. doi: 10.1186/s13098-025-01693-w. Diabetol Metab Syndr. 2025. PMID: 40234912 Free PMC article.
-
Association Between Sensitivity to Thyroid Hormones and Metabolic Dysfunction-Associated Fatty Liver Disease in Euthyroid Subjects: A Cross-Sectional Study.Diabetes Metab Syndr Obes. 2023 Jul 19;16:2153-2163. doi: 10.2147/DMSO.S420872. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 37492438 Free PMC article.
-
Impaired Sensitivity to Thyroid Hormones Is Associated With the Change of Abdominal Fat in Euthyroid Type 2 Diabetes Patients: A Retrospective Cohort Study.J Diabetes Res. 2024 Apr 29;2024:8462987. doi: 10.1155/2024/8462987. eCollection 2024. J Diabetes Res. 2024. PMID: 38712310 Free PMC article.
Cited by
-
Impaired central thyroid hormone sensitivity is associated with time in range in patients with type 2 diabetes mellitus in the euthyroid population.Diabetol Metab Syndr. 2025 Aug 14;17(1):332. doi: 10.1186/s13098-025-01911-5. Diabetol Metab Syndr. 2025. PMID: 40814123 Free PMC article.
-
When Should the Treatment of Obesity in Thyroid Disease Begin?Biomedicines. 2025 Jan 10;13(1):157. doi: 10.3390/biomedicines13010157. Biomedicines. 2025. PMID: 39857741 Free PMC article. Review.
-
Impact of polycyclic aromatic hydrocarbon exposure on thyroid hormone sensitivity: a cross-sectional study of urinary metabolites in 2356 adults from NHANES.BMJ Open. 2025 May 24;15(5):e098106. doi: 10.1136/bmjopen-2024-098106. BMJ Open. 2025. PMID: 40413051 Free PMC article.
References
-
- Ladhani M, Craig JC, Irving M, Clayton PA, Wong G. Obesity and the risk of cardiovascular and all-cause mortality in chronic kidney disease: a systematic review and meta-analysis. Nephrol Dial Transplant. 2017;32(3):439–449. - PubMed
LinkOut - more resources
Full Text Sources